Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
N Engl J Med
; 385(19): 1761-1773, 2021 11 04.
Article
de En
| MEDLINE
| ID: mdl-34525277
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Immunogénicité des vaccins
/
Vaccins contre la COVID-19
/
COVID-19
Type d'étude:
Clinical_trials
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limites:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
N Engl J Med
Année:
2021
Type de document:
Article
Pays de publication:
États-Unis d'Amérique